Frankfurt - Delayed Quote EUR
Q32 Bio Inc. (DB0.F)
1.5600
-0.0500
(-3.11%)
At close: April 25 at 3:49:30 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DB0.F | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/12/2025 |
| Downgrade | BMO Capital: Outperform to Market Perform | 2/11/2025 |
| Downgrade | Piper Sandler: Overweight to Neutral | 2/11/2025 |
| Maintains | BMO Capital: Outperform to Outperform | 12/12/2024 |
| Downgrade | Guggenheim: Buy to Neutral | 12/12/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 12/11/2024 |
Related Tickers
2509.HK Qyuns Therapeutics Co., Ltd.
10.960
+3.59%
CLYM Climb Bio, Inc.
1.2700
-2.31%
EQ Equillium, Inc.
0.4382
-4.74%
HNSA.ST Hansa Biopharma AB (publ)
28.36
+19.76%
TVRD Tvardi Therapeutics, Inc.
18.85
+5.90%
SAGE Sage Therapeutics, Inc.
7.79
0.00%
FOLD Amicus Therapeutics, Inc.
7.35
+2.08%
AVTE Aerovate Therapeutics, Inc.
2.6800
-1.47%
XFOR X4 Pharmaceuticals, Inc.
0.1900
+1.50%
ONC BeiGene, Ltd.
244.90
-4.40%